T3D Therapeutics, Inc.
Durham, United States (US) · Health and Medical
Do your work at T3D Therapeutics, Inc.?
Claim this profile to manage your company.
Verified by Enterprise League
Data quality
Complete · Accuracy
Last verified
May 2026
T3D Therapeutics is a Durham, North Carolina-based biotechnology company focused on developing a transformative, disease-modifying treatment for Alzheimer’s disease and other neurodegenerative disorders.Our core mission centers on addressing the root causes of Alzheimer’s – specifically, brain ‘starvation’ and dysfunction – by targeting metabolic and lipid imbalances within the brain.
Overview
Our core mission centers on addressing the root causes of Alzheimer’s – specifically, brain ‘starvation’ and dysfunction – by targeting metabolic and lipid imbalances within the brain. We believe that Alzheimer’s is fundamentally a neuro-metabolic disease, and our lead drug candidate, T3D-959, is designed to combat this underlying issue.
T3D-959 represents a ‘First-in-Class’ approach, with the potential to slow, stop, or even reverse the progression of the disease by improving memory, motor function, and cognition. We are also exploring applications for Huntington’s Disease, leveraging our expertise in metabolic dysfunction.
Founded in 2013, T3D Therapeutics is driven by a team of experienced scientists and industry leaders, supported by a strong Scientific Advisory Board and Board of Directors.
Contact Details
Durham, United States (US), 68 T W Alexander Drive
Company Type
Private Limited Company
Employees
2-10
Categories
Companies teams usually look at after T3D Therapeutics, Inc.
Comparing a few options usually leads to better decisions
Save companies to compare later. Useful when sharing options with your team
This is how your company profile looks to others.